Exact Mass: 471.19267780000007
Exact Mass Matches: 471.19267780000007
Found 180 metabolites which its exact mass value is equals to given mass value 471.19267780000007
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Dabigatran
C25H25N7O3 (471.20187799999997)
C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173066 - Direct Thrombin Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Hydroxydesmthyl doxepin glucuronide
Hydroxydesmthyl doxepin glucuronide is a metabolite of doxepin. Doxepin is a psychotropic agent with tricyclic antidepressant and anxiolytic properties, known under many brand-names such as Aponal, the original preparation by Boehringer-Mannheim, now part of the Roche group; Adapine, Doxal, Deptran, Sinquan and Sinequan. As doxepin hydrochloride, it is the active ingredient in cream-based preparations (Zonalon and Xepin) for the treatment of dermatological itch. (Wikipedia)
N-(4-(2-(2,3-Dihydrobenzo(b)furan-7-carboxamido)ethyl)benzenesulfonyl)-N'-cyclohexylurea
C24H29N3O5S (471.18278240000006)
Dabigatran
C25H25N7O3 (471.20187799999997)
C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173066 - Direct Thrombin Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
3-[3-Tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-propan-2-ylindol-2-yl]-2,2-dimethylpropanoic acid
C27H34ClNO2S (471.1998654000001)
D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors
1H-Indole-2-propanoic acid, 1-[(4-chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-Alpha,Alpha-dimethyl-5-(1-methylethyl)- [CAS]
C27H34ClNO2S (471.1998654000001)
Ala His Met Asn
C18H29N7O6S (471.18999340000005)
Ala His Asn Met
C18H29N7O6S (471.18999340000005)
Ala Met His Asn
C18H29N7O6S (471.18999340000005)
Ala Met Asn His
C18H29N7O6S (471.18999340000005)
Ala Asn His Met
C18H29N7O6S (471.18999340000005)
Ala Asn Met His
C18H29N7O6S (471.18999340000005)
Cys Gly His Arg
C17H29N9O5S (471.20122640000005)
Cys Gly Arg His
C17H29N9O5S (471.20122640000005)
Cys His Gly Arg
C17H29N9O5S (471.20122640000005)
Cys His Asn Val
C18H29N7O6S (471.18999340000005)
Cys His Arg Gly
C17H29N9O5S (471.20122640000005)
Cys His Val Asn
C18H29N7O6S (471.18999340000005)
Cys Asn His Val
C18H29N7O6S (471.18999340000005)
Cys Asn Val His
C18H29N7O6S (471.18999340000005)
Cys Arg Gly His
C17H29N9O5S (471.20122640000005)
Cys Arg His Gly
C17H29N9O5S (471.20122640000005)
Cys Val His Asn
C18H29N7O6S (471.18999340000005)
Cys Val Asn His
C18H29N7O6S (471.18999340000005)
Gly Cys His Arg
C17H29N9O5S (471.20122640000005)
Gly Cys Arg His
C17H29N9O5S (471.20122640000005)
Gly His Cys Arg
C17H29N9O5S (471.20122640000005)
Gly His Met Gln
C18H29N7O6S (471.18999340000005)
Gly His Gln Met
C18H29N7O6S (471.18999340000005)
Gly His Arg Cys
C17H29N9O5S (471.20122640000005)
Gly Met His Gln
C18H29N7O6S (471.18999340000005)
Gly Met Gln His
C18H29N7O6S (471.18999340000005)
Gly Gln His Met
C18H29N7O6S (471.18999340000005)
Gly Gln Met His
C18H29N7O6S (471.18999340000005)
Gly Arg Cys His
C17H29N9O5S (471.20122640000005)
Gly Arg His Cys
C17H29N9O5S (471.20122640000005)
His Ala Met Asn
C18H29N7O6S (471.18999340000005)
His Ala Asn Met
C18H29N7O6S (471.18999340000005)
His Cys Gly Arg
C17H29N9O5S (471.20122640000005)
His Cys Asn Val
C18H29N7O6S (471.18999340000005)
His Cys Arg Gly
C17H29N9O5S (471.20122640000005)
His Cys Val Asn
C18H29N7O6S (471.18999340000005)
His Gly Cys Arg
C17H29N9O5S (471.20122640000005)
His Gly Met Gln
C18H29N7O6S (471.18999340000005)
His Gly Gln Met
C18H29N7O6S (471.18999340000005)
His Gly Arg Cys
C17H29N9O5S (471.20122640000005)
His Met Ala Asn
C18H29N7O6S (471.18999340000005)
His Met Gly Gln
C18H29N7O6S (471.18999340000005)
His Met Asn Ala
C18H29N7O6S (471.18999340000005)
His Met Gln Gly
C18H29N7O6S (471.18999340000005)
His Asn Ala Met
C18H29N7O6S (471.18999340000005)
His Asn Cys Val
C18H29N7O6S (471.18999340000005)
His Asn Met Ala
C18H29N7O6S (471.18999340000005)
His Asn Val Cys
C18H29N7O6S (471.18999340000005)
His Gln Gly Met
C18H29N7O6S (471.18999340000005)
His Gln Met Gly
C18H29N7O6S (471.18999340000005)
His Arg Cys Gly
C17H29N9O5S (471.20122640000005)
His Arg Gly Cys
C17H29N9O5S (471.20122640000005)
His Val Cys Asn
C18H29N7O6S (471.18999340000005)
His Val Asn Cys
C18H29N7O6S (471.18999340000005)
Met Ala His Asn
C18H29N7O6S (471.18999340000005)
Met Ala Asn His
C18H29N7O6S (471.18999340000005)
Met Gly His Gln
C18H29N7O6S (471.18999340000005)
Met Gly Gln His
C18H29N7O6S (471.18999340000005)
Met His Ala Asn
C18H29N7O6S (471.18999340000005)
Met His Gly Gln
C18H29N7O6S (471.18999340000005)
Met His Asn Ala
C18H29N7O6S (471.18999340000005)
Met His Gln Gly
C18H29N7O6S (471.18999340000005)
Met Asn Ala His
C18H29N7O6S (471.18999340000005)
Met Asn His Ala
C18H29N7O6S (471.18999340000005)
Met Gln Gly His
C18H29N7O6S (471.18999340000005)
Met Gln His Gly
C18H29N7O6S (471.18999340000005)
Asn Ala His Met
C18H29N7O6S (471.18999340000005)
Asn Ala Met His
C18H29N7O6S (471.18999340000005)
Asn Cys His Val
C18H29N7O6S (471.18999340000005)
Asn Cys Val His
C18H29N7O6S (471.18999340000005)
Asn His Ala Met
C18H29N7O6S (471.18999340000005)
Asn His Cys Val
C18H29N7O6S (471.18999340000005)
Asn His Met Ala
C18H29N7O6S (471.18999340000005)
Asn His Val Cys
C18H29N7O6S (471.18999340000005)
Asn Met Ala His
C18H29N7O6S (471.18999340000005)
Asn Met His Ala
C18H29N7O6S (471.18999340000005)
Asn Val Cys His
C18H29N7O6S (471.18999340000005)
Asn Val His Cys
C18H29N7O6S (471.18999340000005)
Gln Gly His Met
C18H29N7O6S (471.18999340000005)
Gln Gly Met His
C18H29N7O6S (471.18999340000005)
Gln His Gly Met
C18H29N7O6S (471.18999340000005)
Gln His Met Gly
C18H29N7O6S (471.18999340000005)
Gln Met Gly His
C18H29N7O6S (471.18999340000005)
Gln Met His Gly
C18H29N7O6S (471.18999340000005)
Arg Cys Gly His
C17H29N9O5S (471.20122640000005)
Arg Cys His Gly
C17H29N9O5S (471.20122640000005)
Arg Gly Cys His
C17H29N9O5S (471.20122640000005)
Arg Gly His Cys
C17H29N9O5S (471.20122640000005)
Arg His Cys Gly
C17H29N9O5S (471.20122640000005)
Arg His Gly Cys
C17H29N9O5S (471.20122640000005)
Val Cys His Asn
C18H29N7O6S (471.18999340000005)
Val Cys Asn His
C18H29N7O6S (471.18999340000005)
Val His Cys Asn
C18H29N7O6S (471.18999340000005)
Val His Asn Cys
C18H29N7O6S (471.18999340000005)
Val Asn Cys His
C18H29N7O6S (471.18999340000005)
Val Asn His Cys
C18H29N7O6S (471.18999340000005)
MK 886
C27H34ClNO2S (471.1998654000001)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclohexylamino)-2-oxoethyl]-7-methyl-N-(2-methylphenyl)- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclohexylamino)-2-oxoethyl]-7-methyl-N-(3-methylphenyl)- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclohexylamino)-2-oxoethyl]-7-methyl-N-(4-methylphenyl)- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2,3-dimethylphenyl)-7-methyl- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2,4-dimethylphenyl)-7-methyl- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2,5-dimethylphenyl)-6-methyl- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2,5-dimethylphenyl)-7-methyl- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2-ethylphenyl)-7-methyl- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(3,5-dimethylphenyl)-7-methyl- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(4-ethylphenyl)-6-methyl- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(4-ethylphenyl)-7-methyl- (9CI)
C28H29N3O2S (471.19803740000003)
Muramic acid,N-acetyl-1-O-(phenylmethyl)-4,6-O-(phenylmethylene)- (9CI)
2-[[7-(acetylamino)-6-(benzyloxy)-2-phenylperhydropyrano[3,2-d][1,3]dioxin-8-yl]oxy]propanoic acid
LDS 751 dye
C25H30ClN3O4 (471.19247300000006)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes
Platensimycin A3 Methyl Ester
A polycyclic cage that is the methyl ester derivative of 7-hydroxy substituted platensimycin. It is isolated from Streptomyces platensis.
2-[3a-[1-(furan-3-yl)-5,8a-dimethyl-3-oxo-4,6,7,8-tetrahydro-1H-isochromen-6-yl]-2,2-dimethyl-6-oxo-3,4,7,7a-tetrahydrofuro[3,2-c]pyran-3-yl]acetate
3-ethyl-2-[(E)-2-[(E)-(3-ethyl-5,6-dimethyl-1,3-benzothiazol-2-ylidene)methyl]but-1-enyl]benzo[g][1,3]benzothiazol-3-ium
Platensimycin A4 Methyl Ester
A polycyclic cage compound isolated from Streptomyces platensis.
Platensimycin A1 Methyl Ester
A polycyclic cage that is the methyl ester derivative of platensimycin A1. It is isolated from Streptomyces platensis.
Platensimycin A2 Methyl Ester
A polycyclic cage that is the methyl ester derivative of 11-hydroxy substituted platensimycin. It is isolated from Streptomyces platensis.
(4R,5R)-5-(2-azidophenyl)-2-[4-(3-hydroxypropoxy)phenyl]-4-(phenylmethyl)-5H-oxazole-4-carboxamide
2-[(2S,3S,6R)-3-[(2-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C21H30FN3O6S (471.18392520000003)
2-[(2R,3R,6S)-3-[(2-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(3-morpholin-4-ylpropyl)acetamide
C21H30FN3O6S (471.18392520000003)
(2R,3R,3aS,9bS)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-6-oxo-1-[oxo(2-pyrazinyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
2-[(2S,3R,6R)-3-[(2-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(3-morpholin-4-ylpropyl)acetamide
C21H30FN3O6S (471.18392520000003)
2-[(2R,3S,6R)-3-[(2-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C21H30FN3O6S (471.18392520000003)
2-[(2S,3R,6S)-3-[(2-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C21H30FN3O6S (471.18392520000003)
2-[(2R,3R,6R)-3-[(2-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C21H30FN3O6S (471.18392520000003)
N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
2-[(2R,5R,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2R,5R,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2S,5R,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
[(1S)-7-methoxy-1-[(3-methoxyphenyl)methyl]-2-methylsulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C24H29N3O5S (471.18278240000006)
2-[(2R,3S,6S)-3-[(2-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C21H30FN3O6S (471.18392520000003)
2-[(2S,3S,6S)-3-[(2-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C21H30FN3O6S (471.18392520000003)
N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
2-[(2S,5R,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2R,5S,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2S,5S,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2R,5S,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
(2S,3S,3aR,9bR)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-6-oxo-1-[oxo(2-pyrazinyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
MK886
C27H34ClNO2S (471.1998654000001)
D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors
Z-Gly-Arg-Thiobenzyl ester
C23H29N5O4S (471.19401540000007)
Z-Gly-Arg-Thiobenzyl ester is a chromogenic substrate for plasmogen-activated serine proteases[1].